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1. Introduction 
Wound healing is a multi-factorial physiological process. The complexity of this 
phenomenon makes it prone to several abnormalities. Apart from cellular and biochemical 
components, several enzymatic pathways also become active during repair and help the 
tissue to heal. The goal of this chapter is to introduce the biomaterials community to the 
emerging field of self-healing materials, and also to suggest how one could utilize and 
modify self-healing approaches to develop new classes of biomaterials. On the other hand, 
natural and synthetic gel-like materials, films/membranes, composites, micro-
/nanoparticulate systems have featured heavily in the development of biomaterials for 
wound healing and other tissue-engineering purposes. Nanofibrous membranes are highly 
soft materials with high surface-to-volume ratios, and therefore can serve as excellent 
carriers for therapeutic agents or accelerate wound healing. Biocompatible and 
biodegradable polymer scaffolds combined with cells or biological signals are being 
investigated as alternatives to traditional options for tissue reconstruction and 
transplantation. These approaches are already in clinical use as engineered tissues that 
enhance wound healing and skin regeneration. This chapter covers the recent reports on the 
preparation and biomedical applications of biopolymers and biomaterials based on 
pharmaceutical dosage forms and wound dressing. 
2. Skin structure 
Skin is the largest organ of the integumentary system, comprising 15 % of the body weight. 
It protects the organism against injury and damage, and prevents passing of 
microorganisms and lets water vapour permeation. Substances secreted by glands in the 
epidermis contribute to the preservation of water - electrolyte balance of the body. The skin 
regulates body temperature by vasodilation and vasoconstriction of cutaneous blood 
vessels, and is formed by two main layers, including epidermis covering the body surface, 
and the dermis involving the connective tissue (Junqueria et al, 1992). 
2.1 Epidermis 
The epidermis consists of two different cell layers. It comes into existence whereas ectoderm 
is taking its form. Cells forming the top layer of epithelium undergo keratinisation and form 
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the dead layer of skin. Whereas dead cells are being pushed from the deeper portion of the 
epidermis toward the surface, they are replaced by proliferating cells by mitosis in the basal 
layer. This change is called cytomorphosis. Cytomorphosis takes an average of 15 to 30 days 
for a healthy individual. The basic cell type of epidermis is keratinocytes. The content of the 
keratin constantly changes in the epidermis because keratinocytes undergo changes in 
epidermis and consists of 85 % of total protein of the Stratum corneum (Gartner et al., 2001). 
Keratinocytes synthesize different keratins in different stages of cytomorphosis. Whereas 
basal layer cells include only low molecular weight keratins, cells with high molecular 
weight keratin begin to build the heap structure of the Stratum corneum as the cells move 
upward. Keratins in this layer are cross-connected by disulphide bonds at the same time.  
The epidermis consists of five layers. These are, respectively, from the inside to out 
(Junqueria et al., 1992). 
Stratum basale (germinativum): This layer consists of a single row of cylindrical cells sitting on 
the basal membrane, located on the dermis and basal lamina. This layer is responsible for 
continuous renewal of the epidermis due to the proliferation of cells. Cytoplasmic fibrillar 
protein is found in all cells that form the structure. As proliferating cells migrate towards the 
upper layer, the number of protein filaments increases. 
Stratum spinosum: This is a multi-storey layer composed of polygonal or squamous epithelial 
cells. The cytoplasm and cytoplasmic extensions are filled with bundles of fibrils and 
connected to each other with bridges on the cell surface. These cells are called spino-cellular 
cells, due to the spine-like structures around this layer of cells. All the layers of both Stratum 
basale and Stratum spinosum are called the Malpighian layer. 
Stratum granulosum: This layer consists of small, flat, polygonal-shaped cells. These cells 
contain keratohyalin granules. The number of lamellar structures emerging in the Stratum 
spinosum increases in the Stratum granulosum, their contents are secreted to intercellular 
spaces as accumulating in the periphery of the cell, providing intercellular lipids, which are 
essential for the barrier function of the epidermis. 
Stratum lucidum (Transparent layer): This layer is composed of flat, transparent, and tightly 
gathered cells ranging from 3 to 5 rows. It is a thin layer that is only found in regions where 
the epidermis is thick. The cytoplasm of the transparent layer is filled with a substance 
refracting light called eleidin and cell organelles decrease in this layer. As tonofibrils become 
more numerous and regular, they make the cell membrane thicker. Desmosomes are located 
between cells and the amount of intercellular materials increases.  
Stratum corneum: It is a dead cell layer having no nucleus. Keratin is found in the cytoplasm 
of these cells. Intercellular gaps are full of lipids which are secreted from the lamellar 
structures in the Stratum spinosum and Stratum granulosum. Superficial cells of the Stratum 
corneum shed continuously (desquamation) and new tissue is produced by mitosis of cells in 
the germinal layer. Keratinization occurs with the formation of disulfide groups from 
sulphydryl groups of protein fibrils during migration to the upper layer. These protein 
fibrils make reticulated bundles, forming a substantial long chain by disulfide bonds and 
also including a dense, amorphous matrix between them, composed of keratohyalin 
granules. At this stage, the cell membrane thickens. This layer, formed by the thickening of 
the cell membrane, takes the shape of cornified cells losing its core and other organelles after 
reaching of keratohyalin granules to maximum point and forming of keratin lipids (Gartner 
et al., 2001; Junqueria et al., 1992).  
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2.2 Dermis 
The dermis is a type of elastic, flexible bond tissue locating under epidermis and is 
vascularised, enabling it to provide energy and nutrition to the epidermis. The dermis 
extends limitlessly by integrating to the subcutaneous layer and its thickness varies 
according to the region (Leeson & Leeson, 1981). Its surface contacting the epidermis is 
rough and composed of papillae. Papillae are named Stratum papillare by integrating deep 
surface of the epidermis. Some papillae also contain special nerve endings, called vascular 
papillae (Young & Heath, 2000). The deepest part of dermis is called as Stratum reticulare. 
This layer consists of irregular, dense connective tissue and has rather weak cells, primarily 
fibroblasts and macrophages. Hair follicles are concentrated around sebaceous and sweat 
glands in the dermis (Leeson & Leeson, 1981). 
2.3 Hypodermis 
Hypodermis, the subcutaneous layer, is a loose connective tissue located under the dermis 
and containing varying amounts of flat cells. Collagen and elastic fibrils within its structure 
continue into the dermis. Hair roots also are found in this layer (Junqueria et al., 1992; 
Leeson et al., 1988). The increase in the number of fibrils results in a rigid binding of dermis 
to hypodermis and thus affects the mobility of the skin.  
3. Wounds and burns 
3.1 Types of wounds 
A wound is the disruption of the integrity of anatomical tissues caused by exposure to any 
factor. Wounds are examined under two groups: 
Closed Wounds: This group includes contusion, hematoma and abrasion. Contusion-type 
injuries involve damage to soft tissues, small blood vessels and deep tissue layers, resulting 
in their separation, but the anatomy of the skin remains intact. Oedema, and in later periods, 
atrophy and defective pigmentation are observed in wound and the healing is delayed. 
Vessel rupture or hyperaemia due to vessel damage is called hematoma and wounds such 
as scrapes are termed abrasions. The healing process is very painful because this type of 
wound involves damage to sensory nerves and the wound can easily become infected 
(Mutsaers et al., 1997). 
Open Wounds: This group includes lacerations, cutting-pricking tool wounds, gunshot 
wounds, surgical wounds, insect bites and stings, radionecrosis, vascular neurological and 
metabolic wounds. Wounds except for lacerations cause serious damage to tissues beneath 
the skin. In laceration type wounds, skin and subcutaneous tissue have been destroyed, but 
deep tissues remain healthy. The anatomical integrity of tissues is damaged in cutting-
pricking tool wounds without any tissue damage at the edges of the wound (Aydın, 2000; 
Kapoor & Appleton, 2005). 
Wounds are also classified according to tissue loss. 
Wounds with Tissue Loss: These types of wounds involve damage or loss in some or all of the 
skin layers. Healing occurs via filling of the wound area by granulation tissue typically 
growing from the base of a wound. Wounds that involve tissue loss are collected in two 
groups in proportion to the loss. In superficial wounds, the entire epidermis and the papillar 
layer of the dermis are damaged. The epidermis, all the layers of the dermis and even 
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subcutaneous tissue are damaged in full-thickness wounds covering second group 
(Mutsaers et al., 1997; Porth, 1998; Chanson et al., 2005). 
Wounds without Tissue Loss: These kinds of wounds occur as a result of tissue crushing. The 
severity of bleeding occurring in tissue varies according to the condition of the wound. 
Tissues exposed to this kind of wound heal after granulation tissue formation in minimal 
level in first phase of healing process (Ruszczak, 2003). 
3.2 Types of burns  
Burn is a kind of wound that occurs when skin or organs are damaged by an electrical 
current, heat, chemical or flammable agent effect. It is known that burn-initiated 
pathophysiological events differ from other traumas, may cause death risks and lead to 
increasing capillary permeability, resulting in hypovolemia. Burn causes changes of 
vascular permeability, extravasation of plasma proteins, aggregation of platelets and 
increased fibrinolysis (Yenerman, 1986; Madri, 1990; Atiyeh et al., 2005).  
Burns are divided into 4 groups according to the depth and the affected skin layers: 
3.2.1 First-degree burns 
Only the outer layer of the epidermis and Stratum corneum are damaged in this type of burn, 
and there is no damage in the dermis. First-degree burns generally occur as a result of short-
term heat or flame contact or long-term exposing to intense sunlight. First-degree burn areas 
are characterised by slight oedema, which diminishes after 24 hours. At this stage the skin 
begins to dry, there is no vesicle and infection is not seen. The wound heals within a week 
(Whitney & Wickline, 2003). 
3.2.2 Second-degree burns 
These types of burns are deeper than first-degree burns and necrosis spread into the dermis. 
Damage covers the entire epidermis and some part of dermis. The wound is clinically 
characterised by pain, erythema and bullae. The recovery rate depends on the depth of skin 
injury and formation of infection. Generally, second-degree burns heal spontaneously in a 
short period if infection does not occur. If infection occurs in the wound, it can easily 
convert to third degree burn. 
The burns in this group may be divided into two categories, termed superficial and deep 
dermal second-degree burns (Sparkes, 1997; Whitney & Wickline, 2003): 
Superficial Second Degree Burns: These occur due to short period contact with flame or hot 
liquids. Generally, the upper portion of the Stratum germinativum is damaged in superficial 
second-degree burns. The surface is generally humid because of the leakage of liquid 
plasma from the burned area. Generally, less scarring than the deep dermal burns occurs. 
Recovery usually occurs within 3-4 weeks with zero or very mild scarring (Madri, 1990).  
Deep Dermal Burns: These occur due to contact with chemicals such as flame, hot liquids or 
acids, or exposure to high electrical current. In these types of burns, whereas the 
epidermis is completely burned, damage extends to the Stratum germinativum and the 
bottom section of the dermis. In deep dermal burns, fluid loss and metabolic effects are 
the same as in third-degree burns. Wound pain is very severe during burning and 
hyperanesthesia may occur in some areas. The wound may develop into a third-degree 
burn if infection occurs in the burn area. The time required for re-epithelialisation 
depends on degradation in the dermis, the amount of burnt hair follicles and sweat 
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glands, and the width of infected areas. If the wound is properly preserved, it usually 
closes within 2 months, leaving some scarring on the skin surface. Scarring and 
contracture occur in healing areas where closing lasts longer than 2 months. In this case, it 
is very difficult to distinguish the wound from third-degree burns and treatment of this 
kind of wound will last longer (Porth, 1998; Shakespeare, 2001). 
3.2.3 Third-degree burn 
These kinds of burns result from hot water, fire and prolonged contact with electrical current. 
The wound area exhibits tautness and brightness as the elasticity of the skin is lost, causing 
abnormal shrinkage. In such cases, all structures within the skin sustain damage. The dermis 
and subcutaneous fat are destroyed as a result of coagulation necrosis. Thrombosis occurs in 
vessels under the skin. Increased capillary permeability and oedema is much higher in third-
degree burns than second-degree burns. Skin is damaged in all layers and is characterised by 
autolysis and leukocytoclastic infiltration for 2 or 3 weeks. This event is usually associated 
with suppuration. Capillary bundles and fibroblasts are organised in granulation tissue under 
scar. If the burn affects subcutaneous fat, healing can take much longer. Burn affecting the 
muscle causes increasing in degradation of red blood cells. The care of third-degree burns 
requires removing scar tissue and covering the wound with a graft. If grafting is not carried 
out, a thick layer of granulation is shaped and the contraction of the area follows it. At this 
stage, re-epithelialisation, slightly, occurs on the edge of wound granulation is soft, can be 
infected and healing continues over several months. Permanent deep scars in the skin occur 
following healing in these kinds of wounds and surgical intervention is usually required to 
restore normal appearance (Moulin et al., 2000; Shakespeare, 2001). 
3.2.4 Fourth-degree burns 
This refers to the carbonization of burned tissues.  
4. Wound and burn treatment  
4.1 Developments in the treatment of wounds and burns 
A range of methods has been used to treat wounds, dating back to ancient times. The 
earliest information on wound treatment is found in Egyptian medical documents, called 
the Ebers Papyrus. It is known that ancient Egyptians treated wounds by covering them frog 
skin and castor oil. The results have been limited and partially misleading, although 
humans have used many materials of biological origin in wound and burn treatment 
throughout history and have conducted various experiments on animals. The first wide-
ranging microscopic study was conducted by Hartwell in the 1930s. Hartwell compared 
human wounds to those in pigs, rabbits, dogs and guinea pigs and found that the wound 
healing progress is different in human epithelial and subepithelial surfaces, compared to 
those of animals. If the pathological table of wound healing is also taken into account, it was 
confirmed that pig physiopathology was most similar to humans, followed by that of 
rabbits. Later, Gangjee et al. (1985) conducted studies of percutaneous wound healing. 
Winter et al. (1965) developed animal models of wounds and burns using pigs as a subject 
for wound treatment and concluded that, as the histology of skin and the wound healing 
mechanism differs between animals and humans, animal models or experiments can only 
provide a general indication of wound healing phases. 
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Researchers subsequently sought new materials for use in wound healing, due to the 
disadvantages of traditional dressings such as gauze, paraffin gauze, biological dressings, 
etc. The first synthetic material used for wound coverage was methyl cellulose. The common 
feature of all these materials is the necessity of physical protection from external factors and 
conditions. Many new materials have been used as the wound healing mechanism has 
become better understood. The usage of artificial dressing materials in forms such as film, 
spray, foam and gel have increased significantly in recent years (Shakespeare & 
Shakespeare, 2002; Stashak et al., 2004; Merei, 2004) 
The following characteristics are required for ideal wound and burn dressing (Sheridan & 
Tompkins, 1999; Balasubramani et al., 2001; Jones et al., 2002);  
• ease of application 
• bioadhesiveness to the wound surface 
• sufficient water vapour permeability 
• easily sterilised 
• inhibition of bacterial invasion 
• elasticity and high mechanical strength 
• compatibility with topical therapeutic agents 
• optimum oxygen permeability 
• biodegradability 
• non-toxic and non-antigenic properties 
Average water loss from normal human skin is 250 g/m2/day. In wounded skin, this figure 
can reach up 5000 g/m2/day according to the type of wound. If a wound dressing material 
is thin and has extreme water vapour permeability, it causes accumulation of liquid, 
bacterial growing and delay in recovery (Alper et al., 1982; Fansler et al., 1995). Wound 
coverings should be adequately adhesive to the wound surface and edges. At the end of 
treatment, cover material should also permit removal in such a manner that it does not harm 
any tissues, must not cause toxic or antigenic reactions, and must be biocompatible. The 
materials used should not cause contamination of microorganisms on the wound surface 
and, if possible, it should also prevent the proliferation of bacteria in normal skin flora. 
Wound dressing materials should be easy to apply and have sufficient elasticity and 
mechanical strength to be used in areas especially close to the joints. The surface of the 
dressing material that is in contact with the wound should support the development of 
fibrovascular tissue as creating a convenient platform for wound healing. Adequate 
oxygenation is important in wound healing, so dressing material should provide contact the 
wound with oxygen. In addition, major desirable characteristics are that wound dressing 
materials should be easily sterilised, have a long shelf-life, and be cost-effective (Quinn et 
al., 1985; Lloyd et al., 1998; Stashak et al., 2004).  
4.2 Classification of dressings used in wound and burn treatment 
Materials used to cover wounds and burns are also called artificial skin, as they fulfil the 
functions of normal skin within areas with wounds and partly destroyed skin.  
Wound and burn covering materials are classified as follows (Freyman et al., 2001; Stashak 
et al., 2004); 
1. Traditional dressing 
2. Biomaterial-based dressings 
3. Artificial dressings 
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4.2.1 Traditional dressing  
These are still the most commonly used materials for wound and burn dressings 
(Balasubramani et al, 2001). The traditional dressings, which are generally used during first 
intervention in wound treatment, prevent wound’s contact with outer environment and 
bleeding (Sheridan & Tompkins, 1999; Stashak et al., 2004). The best sample of this group is 
gauze and gauze-cotton composites which have very high absorption capacity. As they 
cause rapid dehydration whereas they are being removed from the wound surface, they can 
cause bleeding and damage of newly formed epithelium (Naimer & Chemla, 2000; Stashak 
et al, 2004). Therefore, gauze composites with a non-adhesive inner surface are prepared to 
reduce the pain and trauma which can occur when removing traditional wound dressings 
from the wound surface.  
Traditional wound dressings in the world market are shown in Table 1.  
 
Dressing material Brand name Manufacturer 
Paraffin gauze dressing containing 
0.5% chlorhexidine acetate  
Bactigras Smith & Nephew 
Paraffin gauze dressing Jelonet Smith & Nephew 
Petrolatum gauze Xeroform 
Chesebrough-Pond’s 
Inc. 
Petrolatum gauze containing 3% 
bismuth tribromophenate 
Xeroform 
Chesebrough-Pond’s 
Inc. 
Scarlet Red dressing Scarlet Red 
Chesebrough-Pond’s 
Inc. 
Sterile hydrogel dressing 2nd skin® Spenco 
Highly absorbent cotton wool pad Gamgee® pad 3M 
Highly absorbent rayon/cellulose 
blend sandwiched with a layer of anti-
shear high density polyethylene 
Exu Dry Dressing 
Smith & Nephew  
 
Absorbent cotton pad 
Telfa "Ouchless" 
Nonadherent Dressings 
Kendall (Covidien) 
 
Table 1. Traditional wound dressings in the world market. 
Exudate leaking from traditional dressing materials usually increases the risk of infection 
and is one of the most significant problems of these type dressings. Antibacterial agents are 
added into the dressings to eliminate the infection. In addition, one of the most significant 
problems encountered in this material is foreign body reaction in the wound caused by 
cotton fibres. The biggest advantage of these materials is their low cost (Lim et al., 2000; 
Price et al., 2001; Stashak et al., 2004).  
4.2.2 Biomaterial-based dressings  
The most convenient method used in complete closure of wounds and burns is autografting. 
However, inadequate donor areas for large wounds led to the search for a new tissue source 
(Sheridon et al., 2001). Biological dressings are natural dressings with collagen-type 
structures, generally including elastin and lipid.  
Such dressings can mainly be categorised under the following groups (Sheridon et al., 2001; 
Kearney, 2001). 
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1. Allografts  
2. Tissue derivatives  
3. Xenografts 
Some biomaterial-based dressings, which were used for the treatment of wounds and burns, 
is shown in Table 2. 
 
Type of 
dressing 
Dressing material Brand name References/ 
Manufacturer 
Allograft Scalp tissue -------  Barnett et al. (1983) 
Amniotic membrane ------- Peters and Wirth 
(2003) 
Xsenograft 
 
Porcine tissue  
Silver impregnated porcine 
tissue 
Mediskin 
E-Z derm 
Genetic Lab. 
Genetic Lab. 
Skin derivatives 
 
Highly purified bovine collagen 
Formaline fixed skin 
------- 
------- 
Chvapil et al. (1973) 
Chvapil et al. (1973) 
Table 2. Biomaterial-based dressings. 
Allografts 
The most common source for this type of dressing is fresh or freeze-dried skin fragments 
taken from the patient’s relatives or cadavers. Immune reaction as a result of the use of 
allograft can be seen and the body may reject the tissue. Infection risk also increases with 
suppression of the immune system to prevent the body’s rejection of transplanted tissue. 
The other disadvantages of these dressings include the difficulty of preparation, lack of 
donors, high cost and limited shelf life (Nanchahal et al., 2002; Ruszczak, 2003).  
Amniotic membrane, which is separated from chorion, generally uses in superficial partial 
thickness burns as a dressing material for many years (Ravishanker et al., 2003). Though it 
has advantages such as ease of preparation and use, it has disadvantages like causing cross-
infection and dehydration of the wound (Freyman et al., 2001; Jones et al., 2002). Amniotic 
membrane derived from a healthy donor is shown in Figure 1. 
 
 
Fig. 1. The cryo-preserved amniotic membrane was thawed prior to its application 
(Hasegawa et al., 2007). 
The effectiveness of amniotic membranes as dressing materials in burn treatment is 
summarized in Table 3. 
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Dressing quality  Amniotic membrane 
Pain relief +++ 
Infection prevention +++ 
Good adherence to wound bed +++ 
Promotion of re-epithelialisation +++ 
Cost factor ++ 
Moist wound healing environment ++ 
Elasticity/conformability +++ 
Easy application ++ 
Prevention of heat loss + 
Availability ++ 
+++, very good; ++, average; +, below average 
Table 3. Qualities of an ideal dressing for partial-thickness burns (Branski et al., 2008). 
In vitro epidermal cell cultures are new and currently expensive systems used to prepare 
dressing materials. These can be applied in the form of autologous or homologous epithelial 
cell cultures and are still at the development stage (Beckenstein et al., 2004; Manwaring et 
al., 2004).  
Xenografts 
Xenografts are commercially available materials contrary to autografts and allografts. The 
most common of xenografts is the ones derived from pig skin (Sheridan et al., 2001) which 
have a long shelf-life and can be sterilized easily (Sheridan & Tompkins, 1999). Although pig 
skin is not microscopically similar to human skin, it shows close similarity in terms of 
adhesion and collagen content. Its disadvantage is the risk of triggering an immune 
response due to the foreign tissue. 
Tissue derivatives 
These materials, derived from different forms of collagen, have the advantages like ease of 
preparation, low contamination risk and weak antigenic features. The greatest disadvantage 
of these materials is the risk of infection, particularly in long term usage (Jones et al., 2002; 
Stashak et al., 2004). 
4.2.3 Artificial dressings 
The usage of traditional dressing materials and biomaterial-based dressings is restricted due 
to factors such as their stability problems and risk of infection. These conditions brought up 
the use of wound and burn dressing materials being cheaper and more effective, and having 
long shelf-life. Many dressing materials have ideal features for the treatment of wounds and 
burns; however, due to the variations between pathophysiology of the wound and burn, it is 
difficult to develop an artificial dressing material that meets all the criteria for optimum 
healing. Much research is currently being undertaken studies to develop wound dressing 
materials that can provide optimum healing conditions, taking into account all of these 
factors and healing mechanisms (inflammation, tissue replacement, fibrosis, coagulation, 
etc.) (Still et al., 2003; Stashak et al., 2004).  
Some of artificial wound and burn dressing materials in world market are shown in Table 4.  
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Type Dressing material Brand name Company 
  Omiderm Omicron Scientific 
 Polyurethane Opsite Smith & Nephew 
  Bioclusive Johnson & Johnson 
Film/membrane  Tegaderm 3M 
 Polyvinyl chloride Strech Neal Colgate 
 Nylon velour Capran77C Allied Chemical Corp. 
 Polyvinylidene chloride Saran Wrap Asahi Kasei 
 Polyurethane hydrocolloid  Granuflex ConvaTec  
 Synthetic fibre + aluminium Aluderm Söhngen 
 Synthetic fibre + metal Scanpore tape Norgeplaster 
 Activated charcoal Carbopad Charcoal 
 Formalinized polyvinyl alcohol Ivalon Chardack 
Foam Polyurethane Lyofoam Ultra Labs 
 Poly(dimethylsiloxane) Silastic Dow Corning 
 Calcium alginate Kaltostat ConvaTec  
Gel 
Polyurethane with grafted 
acrylamide and 
hydroxyethylmethacrylate 
Omiderm Omicron Scientific 
 
Composite 
Polyprophylene film and 
polyurethane foam 
Epigard Parke-Davis 
 Silicone film with a nylon fabric Biobrane Smith & Nephew 
 
Spray 
Methacrylic acid ethoxyethyl 
ester 
Nobecutane Astra Zeneca 
 
Polyhydroxyethylmethacrylate 
and polyethylene glycol 400 
Hydron Hydron Lab. 
Table 4. Artificial wound and burn dressings in world market. 
4.2.3.1 Polymers used for artificial dressings 
Many natural and synthetic polymers are being used in the preparation of artificial dressing 
materials. 
The most widely used of these includes:  
a. Natural polymers  
Collagen 
Collagen is a biodegradable and biocompatible protein mostly found in connective tissue. 
The first medical usage of collagen in humans was reported by Knapp et al. (1977) and was 
used to provide co-reaction of contour deformities. Bovine collagen was used as suture and 
hemostatic agents after years. In 1980, Zyderm 1 was released, a suspension form containing 
sterilised fibrillar bovine collagen that was used for injecting under the dermis in wounds. 
Today, collagen is used in numerous biomedical applications (Hafemann et al., 1999; Ortega 
& Milner, 2000). These include collagen suspensions for dermal injection, topical 
haemostatic agents, wound dressing materials, collagen suture and catguts, collagen gels for 
periodontal reconstruction, collagen sponges for the hemostasis and coating of joint, and 
collagen rich pig skin wound dressing materials (Gingras et al., 2003; Park et al., 2004). 
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Alginic acid and its salts 
Alginic acid, is a natural polysaccharide derived from brown algae such as Laminaria and 
Ascophyllum species. Alginic acid are formed by linear block copolymerization of D-
mannuronic acid and L-guluronic acid. Alginic acid and its salts are used for the treatment 
of wound and burn due to their haemostatic properties. Their first applications were in the 
form of a gel, but sponges produced from calcium alginate are also used effectively in the 
treatment of wounds. It is also indicated that calcium alginate increases cellular activity 
properties such as adhesion and proliferation (Thomas, 2000a, 2000b and 2000c). 
Hyaluronic acid and its derivatives 
Hyaluronic acid is a natural biopolymer that alternately consists of D-glucuronic acid and 2-
acetamido-2-deoxy-D-glucose and is generally found in mammal’s bond tissues and synovial 
fluids (Saliba, 2001; Kirker et al., 2002). It has been reported that hyaluronic acid interacts with 
proteins, proteoglycans, growth factors and tissue components called biomolecules which has 
vital importance in healing of various types of wounds (Park et al., 2003). This interaction 
plays an important role in acceleration of tissue repair and wound healing. Hyaluronic acid 
and its derivatives also play a role in the protection of the injured area against microorganisms 
due to their bacteriostatic activity (Miller et al., 2003; Lobmann et al., 2003).  
Chitosan 
Chitosan, which is produced by deacetylation of kitin, is a linear polysaccharide composed 
of randomly distributed β-(1-4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-
glucosamine (acetylated unit) (Muzzarelli & Muzzarelli, 2002; Krajewska, 2004). Chitosan is 
used in the treatment of wounds and burns due to its haemostatic effect (Ueno et al., 1999; 
Khor & Lim, 2003; Şenel & McClure, 2004). It is thought that chitosan accelerates the 
formation of fibroblasts and increases early phase reactions related to healing (Paul & 
Sharma, 2004). Chitosan can be prepared in a variety of forms, namely films, hydrogels, 
fibres, powders and micro-/nanoparticles. Applications of this biopolymer in commercial 
and biomedical fields have increased due to the low toxicity of chitosan and its 
biodegradation products, and its biocompatibility with blood and tissues (Berthold et al., 
1994; Cho et al., 1999; Tan et al., 2001; Ishihara et al., 2002; Kim et al., 2002; Mi et al., 2002).  
Fucoidan 
Fucoidan is a sulphated polyfucose polysaccharide and has attracted considerable 
biotechnological research interest since the discovery that it possessed anti-coagulant 
activity similar to that of heparin and also reported to possess other properties including 
anti-thrombotic, anti-inflammatory, anti-tumoral and anti-viral effects (Patankar et al., 1993). 
Many of these effects are thought to be due to its interaction with growth factors such as 
basic fibroblast growth factor (bFGF) and transforming growth factor-β (TGF-β). Fucoidan 
may, therefore, be able to modulate growth factor-dependent pathways in the cell biology of 
tissue repair (O'Leary et al., 2004). In recent years, the research on drug and gene delivery 
systems, diagnostic microparticles and wound and burn healing formulations of fucoidan 
has been increasing in course of time (Sezer et al., 2008a and 2008b, Sezer & Akbuğa, 2009). 
Poly-N-acetyl glucosamine 
Poly-N-acetyl glucosamine which is produced from marine microalgae, has hemostatic 
activity and are used as a support material in the treatment of burns and wounds 
(Pietramaggiori et al., 2008). 
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b. Synthetic polymers 
Polyurethanes and their derivatives 
Polyurethanes are copolymers containing urethane groups in their structures. In general, 
they are formed by conjugation of diol groups and diisocyanate groups with polymerisation 
reaction (Trumble et al., 2002). A large number of non-toxic polyurethanes are synthesized 
for use in biomedical applications. One of these, Pellethane 2363-80A which accelerates re-
epithelialisation was used as dressing material in the treatment of burn and wound (Wright 
et al., 1998; Pachulski et al., 2002). 
Teflon 
Teflon is a polymer that is synthesized by polymerization of tetrafluoroethylene at high 
temperature and pressure. Teflon is an inert material which is non-carcinogenic, insoluble in 
polar and nonpolar solvents, and which can be sterilized. It can take the desired shape by 
application of low-pressure and can easily be applied to the injured area (Raphael et al., 
1999; Lee & Worthington, 1999). 
Proplast 
Proplast which is the first synthetic biomaterial, specially developed for implant 
applications. It is among the particularly preferred materials in wound, burn and surgical 
applications due to its high biocompatibility with tissue (Şenyuva et al., 1997). 
Methyl methacrylate 
Methyl methacrylate is a non-biodegradable synthetic polymer that is resistant to heat and 
UV. It is used as a dressing and supporting material in plastic surgery and the treatment of 
injuries (Nakabayashi, 2003). 
Silicon 
Silicon is used extensively for biomedical purposes. It has low toxicity, low allergic 
properties and high biocompatibility in the body (O’Donovan et al., 1999; Jansson & 
Tengvall, 2001). This polymer, which is resistant to biodegradation, is used in the 
preparation of implant elastomers used in soft tissue repair and in the production of 
hypodermic needles and syringes (Van den Kerckhove et al., 2001; Park et al., 2002). In 
addition, silicon is also often used as wound support material in severe wounds and burns 
due to its high tissue compatibility (Whelan, 2002; Losi et al., 2004). 
4.3 Pharmaceutical formulations used as dressings for wounds and burns 
Many pharmaceutical formulations have been recently developed as synthetic dressing 
material for wound and burn treatment.  
4.3.1 Films/membranes 
These pharmaceutical dosage forms, which are available in thickness ranging from µm to 
mm, are prepared by different methods using one or more polymers. Films are ideal 
dressing materials and available in commercial. Films/membranes with a homogeneous 
polymeric network structure are used to treat the damaged area and generally protect the 
wound and burn area against external factors (Verma & Iyer, 2000; Stashak et al., 2004). The 
polymers used in the preparation of films include; polyurethane, polyvinylpyrrolidone (Yoo 
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& Kim, 2008), hyaluronic acid (Xu et al., 2007; Uppal et al., 2011), collagen (Boa et al., 2008), 
sodium alginate (Kim et al., 2008a and 2008b) chitosan and its derivatives (Tanigawa et al., 
2008), poly-N-acetyl glucosamine (Pietramaggiori et al., 2008) and fucoidan (Sezer et al., 
2007). In a clinical study, as a result of in vitro studies of polyurethane / poly (N-
vinylpyrrolidone) composite film combinations, it was reported that their water absorption 
capacity was high and water vapour permeability was between 1816-2728 g /m2 /day. It 
was seen that recovery in the injured area was significantly increased and a new epithelial 
tissue was formed in 15 day period following application of these prepared formulations to 
full-thickness wounds induced in a rat model (Yoo & Kim, 2008). Tanigawa et al. (2008) 
prepared scaffold formulations by using chitosan citrate and chitosan acetate, which are 
natural polymers, and examined the effectiveness of the formulations on wound healing in 
mice with damaged epidermis. The scaffold, prepared by a lyophilisation method, gave 
quite a distinct pore structure especially inside it, depending on the type of the acid used for 
the preparation of chitosan solution; the pore consisted of fibrous networks appeared in 
chitosan citrate, whereas the pore surround by cell walls occurred in chitosan acetate. 
Despite the large difference in the pore structure, both scaffolds were effective in 
regeneration of the outher skin. However, chitosan citrate scaffold provided better 
facilitation in wound healing than the chitosan acetate one (Tanigawa et al., 2008). 
Commercially available collagen-based film formulations also used in the treatment of 
dermal burns (Boa et al., 2008). In a recent study, the treatment efficacy of collagen-based 
films was investigated in second-degree burns created in 45 Wistar rats. The prepared 
collagen film formulations were applied to the wound alone or in combination with 
liposome formulations containing usnic acid, and then examined after 14 and 21 days. The 
use of the usnic acid provided more rapid substitution of type-III for type-I collagen on the 
14th day, and improved the collagenisation density on the 21st day. It was concluded that 
the use of reconstituted bovine type-I collagen-based films containing usnic acid improved 
burn healing process (Nunes et al., 2011). Differences in healing of wounds are summarized 
in histological sections in Figure 2.  
In another study, the researchers hypothesized that a poly-N-acetyl glucosamine (pGlcNAc) 
fibre patch might enhance wound healing in diabetic (db/db) mice. Wounds dressed with 
pGlcNAc patches for 1 h closed faster than control wounds, reaching 90% closure in 16.6 
days, 9 days faster than untreated wounds. Granulation tissue showed higher levels of 
proliferation and vascularization after 1 h treatment than the 24 h and left-untreated groups. 
Foreign body reaction to the material was not noted in applications up to 24 h 
(Pietramaggiori et al., 2008).  
The primary negative factor affecting healing of burns and wounds is the loss of skin 
integrity. It is indicated in the literature that wound and burn healing occur much more 
quickly with the help of a dressing material (Mutsaers et al., 1997; Kapoor & Appleton, 
2005). Therefore, in recent years, the use of biopolymers has gained priority in tissue 
engineering and biotechnology, both as dressing material and in terms of enhancing 
treatment efficiency (Atiyeh et al., 2005).  
A biopolymer, fucoidan, consisting of fucose and sulphate groups has been used for the 
treatment of burns and wounds (Sezer et al., 2007, 2008a and 2008b). It was reported that 
fucoidan shows anticoagulant effect and heparin activity (Sezer & Cevher 2011). It was also 
reported that films prepared with fucoidan do not prevent contact of the wound surface 
with air oxygen, provide the moisture balance in wound/burn area, accelerate the migration 
of fibroblasts and provide re-epithelialisation (Sezer et al., 2007) (Table 5).  
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Fig. 2. Histological sections stained in hematoxylen-eosin. Seven days: (Ia) Lack of 
inflammatory response in the center of the burned area in COL. (Ib) Inflammatory infiltrate 
rich in polymorphonuclear neutrophils (pmn) in PHO. (Ic) Expressive content of 
polymorphonuclear neutrophils (pmn) in the top of the wound, and early granulation tissue 
(gt) formation in the bottom, in UAL. Fourteen days: (IIa and IIb) Intense acute 
inflammatory reaction (a) scattered within the burned area in COL and PHO, respectively. 
Neutrophils seen in detail. (IIc) Moderate infiltrate of neutrophils and lymphocytes in 
association to expressive fibroblastic proliferation (fb) in UAL. Fibroblasts seen in detail. 
Twentyone days: (IIIa and IIIb) Vascular component (arrows), and chronic inflammatory 
infiltrate, still evident in COL and PHO, respectively. (IIIc) Scanty inflammatory cells are 
seen within the cicatricial tissue (ct) in UAL. *COL—animals treated with collagen-based 
films; PHO—animals treated with collagen films containing empty liposomes; UAL—
animals treated with collagen-based films containing usnic acid incorporated into liposomes 
(Nunes et al., 2011). 
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*MN indicates mononuclear leukocyte; PMNL, polymorphonuclear leukocyte; ─, absent; +, mild; ++, 
moderate; +++, severe; FS, fucoidan solution; CF, chitosan film without fucoidan; and CFF, chitosan 
film containing fucoidan. 
Table 5. The score of the wound cells and collagen (Sezer et al., 2007). 
4.3.2 Gels 
Gels are viscous semi-solid preparations formed by dispersion of inorganic or organic 
substances that have larger size than colloidal particles in a liquid phase. Hydrogels are semi-
solid systems, formed by a combination of one or more hydrophilic polymer. They are among 
the dressing materials frequently used in the treatment of wounds and burns. As they are 
capable of absorbing much more water than their weight, they act as dressing, reducing 
potential irritation when in contact with tissue and other similar structures. They keep 
moisture at the application site and permit oxygen penetration (Hoffman, 2002; Jeong et al., 
2002). Hydrogels have many advantages including patient compliance, treatment efficacy and 
ease of application. The advantages of hydrogels in wound and burn treatment can be listed as 
follows (Kumar et al., 2001; Hoffman, 2002; Jeong et al., 2002; Byrne et al., 2002); 
- Bioadhesion of gels to the surface of the wound is high and this also eases the treatment 
due to increased contact with the wound 
- Their structures facilitate the moisture and water vapour permeability necessary to heal 
the wound area 
- Difficulties that are particularly related to the application to open wounds are not seen 
in these preparations 
- They can easily be removed from the application site when adverse events seen 
Natural polymers are generally preferred in the preparation of hydrogels. Hyaluronan is a 
biopolymer widely used in the treatment of wounds. It is non-toxic, non-immunogenic, and 
has very good resorption characteristics in biomedical applications, which allow this 
biopolymer to be used in the treatment of wounds. In a study, cross-linked glycol 
chitosan/hyaluronan hydrogels was prepared and found that they displayed the 
characteristics required of an ideal wound dressing material (Wang, 2006). Chitosan is 
obtained by partial deacetylation of the amines of chitin. Its use has been explored in 
various biomaterial and medical applications. Chitosan has desirable qualities, such as 
hemostasis, wound healing, bacteriostatic, biocompatibility, and biodegradability 
properties. Chitosan appears to have no adverse effects after implantation in tissues and, for 
this reason, it has been used for a wide range of biomedical applications. Chitosan was also 
used to inhibit fibroplasia in wound healing and to promote tissue growth and 
differentiation in culture (Alsarra, 2009).  
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The efficacy of chitosans with different molecular weights and deacetylation degrees was 
investigated in the treatment of wounds (Sezer, 2011). The treatment efficacy of gels 
prepared with chitosans with low, medium and high molecular weight was examined in a 
rat full-thickness wound model in which the epidermis and dermis had been damaged. 
Chitosan gel formulations were also compared with Fucidin® ointment containing fusidic 
acid. Chitosan was found to promote the migration of the inflammatory cells which are 
capable of the production and secretion of a large repertoire of pro-inflammatory products 
and growth factors at a very early phase of healing. Fucidin® ointment-treated rats revealed 
a site that was not completely healed but more improved and with a smaller lesion than that 
of untreated groups. In comparison with high molecular weight chitosan-treated wounds 
(after 12 days), the wound site was so perfectly healed that it was difficult to distinguish it 
from normal skin (Figure 3) (Alsarra, 2009). 
 
 
Fig. 3. Photographs of macroscopic appearances of wound excised from rats that were 
untreated (control), treated with high molecular weight chitosan (CH-H), or treated with 
Fucidin® ointment (FU) (Alsarra, 2009). 
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The efficacy of chitosan gel formulations containing silver sulfadiazine in the treatment of 
burn was examined. Due to its pseudoplastic characteristic and high bioadhesiveness, the 
chitosan gels with and without silver sulfadiazine showed a satisfactory retention time over 
the wounds. Wounds treated with chitosan gel with silver sulfadiazine showed a higher 
fibroblast production and a better angiogenesis than that of commercially available silver 
sulfadiazine cream, which are important parameters on the evolution of the healing process 
(Nascimento et al., 2009). 
Polyvinyl alcohol hydrogels with different combinations, prepared with chitosan and 
dextran, are also used as wound dressing material. It was recorded that these cross-linked 
hydrogels are capable of ideal water absorption and swelling and provide an ideal moist 
environment necessary for wound healing. In addition, it has been reported in the literature 
that cross-linking of polyvinyl alcohol with dextran and chitosan increases the flexibility 
and elasticity of the gel (Sung et al., 2010; Hwang et al., 2010). 
In another study, the novel thermoreversible wound gel formulation containing 
Polyhexadine showed good results for wound treatment and represented an alternative to 
silver sulfadiazine cream and iodine-based ointment, which are toxic and associated with 
many allergic reactions. The open randomized controlled single-center study was carried 
out on 44 patients in 2 parallel groups (Traumasept®wound covering gel vs. Flammazine®). 
The transparency of the thermosensitive gel formulation and absence of staining allowed for 
good wound assessment, without the need for painful cleaning, and the change from the 
fluid to the gel state enabled easy handling and filling the wound cavities (Goertz et al., 
2010).  
One of the most important parameters of the injured tissue pathology is to stop the bleeding 
and to protect the area with a protective support material in the first step. It is reported that 
hydrogels prepared using oxidised dextran and allylamine hydrochloride decreased 
coagulation and increased cloth strength and consequently are able to decrease the 
haemorrhage in clinical use (Peng & Shek, 2009).  
The use of various proteins in topical wound treatment is also recorded in the literature (Ji et 
al., 2009). Wound treatment efficacy of methylcellulose gel dressings including recombinant 
human vascular endothelial growth factor (rhVEGF) have been examined by Ji et al. (2009). 
The dressings being studied were Adaptic®, Non-stick Dressing, Conformant 2®, 
Opsite®TM and TegaporeTM. The criteria to select a compatible dressing include protein 
stability, absence of leachables from the dressing, and ability to retain gel on wound. Results 
showed that rhVEGF was significantly oxidized by Adaptic dressing in 24 h. Protein 
oxidation was likely due to the peroxides, as determined by ferrous oxidation with xylenol 
orange (FOX) assay, released into the protein solution from the dressing. In conclusion, 
Tegapore™ was considered suitable for the rhVEGF topical gel (Ji et al., 2009).  
A similar study determined the gel properties of sodium carboxymethyl cellulose and 
fusidic acid and aimed to improve them as wound dressings. It was reported that swelling, 
flexibility and elasticity properties of sodium carboxymethyl cellulose (Na-CMC) gels was 
changed depending on sodium fucidate and the cross linker (PVA) content in the 
formulation. Hydrogel formulation containing 2.5% PVA, 1.125% Na-CMC and 0.2% 
sodium fucidate adsorbed exudate from the wound surface adequately and kept the 
moisture sufficiently in wound area and consequently, it was recommended as an ideal 
wound dressing material. (Lim et al., 2010).   
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Hydroxyapatite (HA) and silk fibroin (SF) composites are biomaterials used in wound 
treatment. It was reported that the polarized HA (pHA) transforms the SF structure into a 
porous three-dimensional scaffold. SF gel containing pHA was found to be higher 
promotive effects on wound healing, re-epithelialisation and matrix formation (Okabayashi 
et al., 2009). 
Gelatine is commonly used in the treatment of wounds and burns, and acts as supportive 
tissue when used in the treatment of dermal burns with various biopolymers. 
Balakrishnan et al. (2005) applied hydrogel formulations containing oxidised alginate and 
gelatine to the 1 cm2 full-thickness skin wounds created in rat model and the results 
evaluated histologically. At 15th day, test wounds appeared reduced in size with new 
epithelium noted at both the edges of the defect with the proliferation of basal layer and 
formation of the rete pegs. New collagen formed in the dermis appeared mature. 
Granulation tissue was seen in dermis. Granulation tissue formation is essential for 
permanent wound closure, since it fills the defects and prepares the way for re-
epithelialisation. These findings support that alginate/gelatin hydrogel is able to provide 
suitable condition for granulation tissue formation. At 15th day, in test wounds, the defect 
area became smaller and filled with fibro-proliferative tissue. Inflammatory cells were 
absent. However, for some control wounds though the entire surface of the defect was 
covered with new epithelium, moderate number of inflammatory cells, predominantly 
lymphocytes and macrophages, were still present in the upper dermis. Though 
superficially neither control nor test wounds showed any reduction in defect area at 5th 
day, on measuring the wound re-epithelialisation it was found that both wounds have 
started healing (Balakrishnan et al., 2005). 
In a previous study has shown successful treatment with fucoidan-chitosan hydrogels 
which were tested in New Zealand rabbits with second degree burn (Sezer et al., 2008a). In 
another study, chitin/chitosan, fucoidan and alginate hydrogel blends were prepared and 
the granulation tissue and capillary formation were found to be increased in the first 7 days 
of the treatment of induced wounds (Murakami et al., 2010). 
4.3.3 Sprays and foams 
Sprays are pharmaceutical forms containing the solvent and polymer, forming a film layer 
on the surface of the wound when sprayed. The best example of a spray-based artificial 
wound and burn dressing is Hydron. It is prepared with polyhydroxyethyl methacrylate 
powder and liquid polyethylene glycol. When it is sprayed on the surface of the wound, it 
creates a thin and transparent film layer. In studies it was found that sprays reduce the pain 
of the wound, but have disadvantages including loss of integrity of the dressing and 
accumulation of sub-membrane fluid. Researchers stated that Hydron provides an effective 
treatment when applied to small partial thickness wounds and to areas which are away 
from joints (Dressler et al., 1980; Pruitt & Levine, 1984). Another example of aerosol sprays is 
papain-pectin sprays. The spray-on topical wound debrider composition consisting of 0.1% 
papain immobilized in 6% pectin gel was formulated for skin wound healing. The stability 
of the enzyme activity of this new formulated spray was compared with the 0.1% papain in 
water solution at the refrigerated temperature of 4C. and 75°C. Prepared formulations were 
tested on experimental wounds created on rabbits. In the study groups treated by pectin-
papain aerosol spray compared with a control group.  
www.intechopen.com
 
Biopolymers as Wound Healing Materials: Challenges and New Strategies 401 
During the experiment, no obvious healing process inhibition or side effects were visually 
observed. Upon spray application on the surgical wound, the aerosol formed a thin, smooth, 
and even film staying in place on the wound bedwithout dripping, promoting wound 
healing after drying versus an untreated wound (as control). The spray bottle was easy to 
maneuver; making it possible to reach areas of each wound that otherwise might receive 
inadequate coverage. The progress of healing was overall higher with the spray at 2 times 
more in the first four days of treatment. The difference was calculated to be significant based 
on the Student´s t-test method with the resulting p <0.05. It was concluded that papain 
immobilized in pectin can be used for the development of effective aerosol spray system for 
wound healing in the areas of enzymatic debridement of necrotic tissue and liquefaction of 
slough to remove dead or contaminated tissue in acute and chronic lesions, such as diabetic 
ulcers, pressure ulcers, varicose ulcers, and traumatic infected wounds, postoperative 
wounds, burns, carbuncles, and pilonidal cyst wounds (Jáuregui et al., 2009). 
Lyofoam, polyurethane foam, is normally hydrophobic; however, when applying heat and 
pressure, it becomes hydrophilic and, in this form, while providing blood and exudates 
absorption, it also prevents drying the wound surface completely (Johnson et al., 1998; 
Catarino et al., 2000; Fenn & Butler, 2001; Lehnert & Jhala, 2005).  
4.3.4 Composites 
Composites developed for wound treatment may involve an elastic outer layer with high 
mechanical strength, which is resistant to the effects of the environment and provides 
moisture by preventing evaporation; in contrast, the inner layer provide adhesion of the 
composite to the surface of the wound. Telfa™ is a dressing material, including cotton, 
covered by polyester film and is used both for providing absorption and preventing 
dehydration of the wound surface (Kickhöfen et al., 1986). Clinical studies have been 
conducted of chitin nanofibrils/chitosan glycolate composites (Muzzarelli et al., 2007), 
salmon milt DNA/salmon collagen composites (Shen et al., 2008), polymer-xerogel 
composites (Costache et al., 2010), and autologous cellular gel matrix systems (Weinstein-
Oppenheimer et al., 2010). Chitin and chitosan composites were found to be very promising 
in the treatment of wounds. Muzzarelli et al. (2007) tested the wound treatment activity of 
spray, gel and gauze forms of nanofibrils chitin/chitosan glycolate composites on both 
Wistar male rats and 75 patients between the ages of 45-70. Recovery was particularly good 
when applied gauze to gangrenous tissue (Figure 4).  
It was shown that the nanofibrillar chitin/chitosan glycolate composites appeared to be 
most suitable as medicaments able to exert control over various biochemical and 
physiological processes involved in wound healing besides haemostasis. Whereas chitosan 
provided antimicrobial activity, cell stimulation capacity and filmogenicity, chitin 
nanofibrils restructured the gel, released N-acetylglucosamine slowly and recognised 
proteins and growth factors.  
In another study, Shen et al. (2008) examined the neovascularization and fibrillogenesis 
effects of salmon milt DNA and salmon collagen (SC) composites when used for the 
treatment of wounds. Tissue loss of wounds treated with composites was repaired quickly 
and the epidermal layer was formed quickly by means of sDNA (Shen et al., 2008). 
Biobrane, is a collagen-silicone based composite, uses as a skin graft to treat injuries (Figure 5). 
The outer layer of the membrane is a thin and semi-permeable layer consisting of silicon. 
This layer allows water permeation but prevents the entry of microorganisms. Type I pig 
collagen forms an inner layer with an inert, hydrophilic network structure and provides a 
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suitable platform for the development of granulation tissue. Water transfer can be 
maintained similar to that of natural skin by modifying the membrane thickness (Suzuki et 
al., 1990; Ou et al., 1998; Still et al., 2003).  
 
 
Fig. 4. Gangrenous pyoderma on tibial surface. Treated with Gauze and i.v. therapy of 
steroids and cyclosporine to ameliorate the wound bed. Complete healing in 40 days 
(Muzzarelli et al., 2007). 
 
 
Fig. 5. Schematic observation of biobrane application on superficial to mid-partial thickness 
burn (http://www.burnsurgery.com). 
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Bilaminar composite membranes containing bovine collagen-based dermal analogue and 
silastic epidermis has been developed for the treatment of wounds and burns. It is stated 
that biocompatible bovine collagen-based dermal analogue slowly degrades and provides a 
suitable environment for the development of the patient's connective tissue; in addition, the 
epidermal layer’s water vapour permeability is close to the skin and protects the wound 
from trauma and microorganisms (Still et al., 2003). 
There are certain restrictions in the areas in which skin source materials can be applied as 
dressings. Biodegradable or non-biodegradable unilaminar and bilaminar composite 
membranes function as a serous crust and reduce pain but can not prevent infection. It is 
stated that synthetic composites do not constitute infection, are suitable for use with 
antimicrobial solutions and are easily applied to wound tissue (Van den Kerckhove et al., 
2001; Van Zuijlen et al., 2003). 
4.3.5 Particulate systems 
The biggest advantages of particulate systems are that, when applied locally to open 
wounds, they easily provide water vapour and oxygen permeability of the wound; and have 
large contact surfaces and high bioadhesiveness due to their multiparticulate structures. 
Drug release in the wound area can be controlled with particulate system, and this increases 
the speed of wound healing (Kawaguchi, 2000; Date & Patravale, 2004). 
In recent studies on micro-/nanoparticulate systems in wound and burn treatment, the use 
of nitric oxide nanoparticles (Martinez et al., 2009), poly (ethylene-co-vinyl alcohol) 
nanofiber (Xu et al., 2011), silver nanoparticles (Lakshmana et al., 2010; Xu et al., 2011), 
fucoidan microparticles (Sezer et al., 2008b), collagen sponges (Still et al., 2003; Lee, 2005), 
and liposomes containing epidermal growth factor (Alemdaroglu et al., 2008) have 
examined. Staphylococcus aureus is a gram-positive bacteria, capable of rapidly proliferating 
in the injured area and causing infection, causes superficial and invasive skin infections. 
Wounded skin is suitable media for the growth of such pathogenic microorganisms. Various 
clinical studies have attempted to develop strategies and formulations to address this 
common issue of pathogenic infection. Topically applied nitric oxide (NO) is a potentially 
useful preventive and therapeutic strategy against superficial skin infections, including 
methicillin-resistant Staphylococcus aureus infections. NO modulates immune responses and 
is a significant regulator of wound healing (Martinez et al., 2009). NO nanoparticles were 
prepared by combination of sodium nitrite with tetramethylorthosilicate, polyethylene 
glycol, chitosan, glucose. The mechanisms through which the NO nanoparticles accelerate 
wound healing were further determined by establishing whether NO nanoparticles 
prevented collagen degradation by MRSA in the infected tissue. Collagen content was 
highest in both uninfected and infected wounds treated with NO nanoparticles, although 
nanoparticles-treated uninfected tissue also had high collagen content. The dispersed blue 
stain indicated thicker and more mature tissue collagen formation in wounds treated with 
NO nanoparticles, suggesting that NO nanoparticles exposure maintained dermal 
architecture through bacterial clearance, and ultimately by guarding collagen (Figure 6) 
(Martinez et al., 2009).  
Silver has been used in wound treatment since ancient times. Ointments including silver 
sulfadiazine are also frequently used in the treatment of burns. Silver affects pathogenic 
bacteria in wound and burn areas in different ways. Silver ions interacting with bacterial 
enzymes are taken up inside the bacterial cells, impair the DNA of the bacteria and prevent 
cell proliferation. Silver ions also attach the cell wall and disrupt the integrity of cell 
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membrane and kill the bacteria (Klasen, 2000a and 2000b). Poly (ethylene-co-vinyl alcohol) 
fibre systems including silver nanoparticles were prepared for the treatment of wounds. The 
results showed that the nanofibre size can be controlled by regulating polymer solution 
concentration. It has been reported that high concentration of silver might change the fibre 
morphology. Results of bacterial tests showed that pathogen-restraining ability of the silver-
encapsulated nanofibres was effective and proportional over a range of silver concentration, 
indicating its inflammation control capacity and the potential for applications in skin wound 
treatment (Xu et al., 2011). 
 
 
Fig. 6. NO-nps decrease collagen degradation in skin lesions of Balb/c mice. (a) Histological 
analysis of Balb/c mice uninfected and untreated, uninfected treated with nanoparticles 
without nitric oxide (NO) (np), uninfected treated with NO-nps (NO), untreated methicillin-
resistant Staphylococcus aureus (MRSA)-infected, np-treated MRSA-infected, and MRSA-
infected treated with NO, day 7. Mice were infected with 107 bacterial cells. The blue stain 
indicates collagen. Bar ¼ 25 mm. (b) Quantitative measurement of collagen intensity in 16 
representative fields of the same size for uninfected and untreated, uninfected treated with 
nanoparticles without NO (np), uninfected treated with NO, untreated MRSA-infected, np-
treated MRSA-infected, and MRSA-infected treated with NO wounds. Bars are the averages 
of the results, and error bars denote SDs. *P<0.01 in comparing the untreated groups with 
the uninfected np- and NO-treated groups; **P<0.001 in comparing the untreated groups 
with the MRSA + NO group (Martinez et al., 2009). 
In another study, silver nanoparticles were synthesized by aqueous and organic methods 
and incorporated into electrospun polyurethane (PU) nanofibre to enhance the antibacterial 
as well as wound healing properties. The electrospinning parameters were optimized for PU 
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with and without silver nanoparticles. The water absorption, antibacterial and 
cytocompatibility of the PU-silver nanofibers were studied and compared to that of 
conventional PU foam. The results indicated that the PU-Ag nanofibers could be used for 
wound dressing applications (Lakshmana et al., 2010). 
 
Fig. 7. Days to 100% wound closure. Median times to wound closure is shown in (A) and 
mean times are shown in (B). BCM indicates bilayered cellular matrix (OrCelTM); intent-to-
treat (ITT). ∗Log-rank test of the difference between treatment healing times, stratified by 
patient. †Paired t-test (Still et al., 2003). 
In different stages of wound healing, various cell types, cytokines, coagulation factors, 
growth factors, complement activation and matrix proteins are involved in different extents. 
Collagen is one of the most important structural protein components of connective tissue. It 
is difficult to say at which stage collagen predominates because wound healing is a dynamic 
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event involving many stages. There are many different clinical applications of collagen. For 
example, collagen gel is often used to treat haemophilia patients due to its haemostatic 
effects (Tan et al., 2001; Lee et al., 2002; Ruszczak, 2003; Beckenstein et al., 2004). By using 
microsponge technology, which is a new type of pharmaceutical dosage form, collagen-
based particles are clinically tested in the treatment of wounds and burns and were reported 
to have positive results compared with commercial preparations (Ruszczak, 2003; 
Beckenstein et al., 2004). Still et al. (2003) examined the safety and efficacy of porous 
collagen sponge containing co-cultured allogeneic donor epidermal keratinocytes and 
dermal fibroblasts from human neonatal foreskin tissue (OrCel™) in facilitating timely 
wound closure of split-thickness donor sites in severely burned patients. Utilized a matched 
pairs design; each patient had two designated donor sites of equivalent surface area and 
depth. Sites were randomized to receive a single treatment of either OrCel™ or the standard 
dressing Biobrane-L®. The treatment of donor site wounds with OrCel™ is well tolerated, 
promotes more rapid healing, and results in reduced scarring when compared with 
conventional therapy with Biobrane-L® (Still et al., 2003). Data on wound closure as a result 
of the treatment are given in Figure 7. As seen in Figure 7, the cell based-membrane sponges 
improved the healing of the wound. 
The efficacy of microsponges containing epidermal growth factor (EGF) was investigated 
clinically. It was found that the application of EGF microsponges to the burn surface 
increased the activity of fibrinogen and thus fibroblast synthesis and migration were seen 
at the injury site (Lee, 2005). Also, liposome systems in which EGF had been encapsulated 
was used as particulate carrier systems in the treatment of wounds and burns. Positive 
results were reported in terms of eschar tissue formation and wound healing with these 
systems, when especially used in the treatment of second-degree burns (Alemdaroglu et 
al., 2008). 
5. Conclusion 
The biopolymers are more effective as a wound-healing accelerator than synthetic polymers. 
The wound treated with biopolymers and biomaterials shows accelerated healing. 
Biopolymers structural arrangement is similar to that of normal skin. Consequently, the 
biopolymers are considered to be one of ideal materials with biocompatibility, 
biodegradability, and wound healing property as well as easy application. 
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